• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Digital Pathology

PathGroup Expands Operations with Proscia Concentriq Dx

by Strategic Partnerships 03/01/2023 Leave a Comment

JPC Taps Proscia to Modernize World's Largest Human Tissue Repository

What You Should Know: - PathGroup, one of the largest providers of anatomic, clinical, digital, and molecular pathology services in the United States, is expanding its operations with Proscia's software platform (Concentriq® Dx) to further enhance the delivery of faster, higher quality results for millions of patients, helping to better inform treatment decisions. - PathGroup currently supports more than 15,000 referring physicians and over 200 hospital
Read More

Develop, Partner, Acquire or Avoid – Where’s Investment for Digital Pathology Headed in 2023?

by Imogen Fitt, Market Analyst at Signify Research 02/03/2023 Leave a Comment

Develop, Partner, Acquire or Avoid – Where’s Investment for Digital Pathology Headed?

News of Fujifilm’s recent acquisition of software provider Inspirata’s digital pathology assets was met with much interest last month, following on from robust industry debate at Global Engage’s Digital Pathology and AI Congress: Europe a few weeks prior. Their discussions centered around the progress of the market and its inevitable future developments.  Whilst our in-depth analysis of the implications of Fujifilm’s specific deal will be released soon as a part of our Premium Insights
Read More

Netherlands Cancer Institute to Deploy Proscia’s Pathology Platform

by Fred Pennic 01/18/2023 Leave a Comment

Netherlands Cancer Institute (NKI) to Deploy Proscia’s Pathology Platform To Drive Personalized Diagnosis

What You Should Know:  - Proscia®, a provider of digital and computational pathology solutions, announced that the Netherlands Cancer Institute (NKI), one of the top 10 comprehensive cancer centers in Europe, will deploy its Concentriq® Dx platform.  - NKI is transitioning to Concentriq Dx to expand its digital pathology practice, laying the foundation for its pathologists to deliver personalized diagnoses that better inform treatment decisions. In doing so, the cancer center,
Read More

Research: Proscia AI Predicts Diagnostic Agreement for Melanoma

by Syed Hamza Sohail 11/02/2022 Leave a Comment

JPC Taps Proscia to Modernize World's Largest Human Tissue Repository

What You Should Know: - Proscia® a provider of digital and computational pathology solutions, has released study results on new artificial intelligence (AI) that predicts diagnostic agreement for melanoma, the deadliest form of skin cancer. - The findings, which were presented at the European Conference on Computer Vision (ECCV) 2022, highlight the potential of the technology to improve diagnostic accuracy for melanoma and other diseases with low pathologist concordance. Findings
Read More

Proscia Unveils New Enhancements to its Digital Pathology Platform

by Syed Hamza Sohail 10/12/2022 Leave a Comment

Proscia Unveils New Enhancements to its Digital Pathology Platform

What You Should Know: - Proscia®, a leading provider of digital and computational pathology solutions, has introduced the next version of its Concentriq® Dx platform for primary diagnostic workflows, which is CE-marked under IVDR. - The release brings together new features and a compelling user experience to help even the largest laboratory networks transition to 100% digital diagnosis. In doing so, they can realize the full promise of the shift away from microscope-based
Read More

KLAS: State of Digital Pathology Among Early Adopters in 2022

by Syed Hamza Sohail 10/07/2022 Leave a Comment

KLAS: State of Digital Pathology Among Early Adopters in 2022

What You Should Know: - In anticipation, many technology vendors are vying for a foothold in the US, leading to a highly varied landscape. In partnership with the Digital Pathology Association (DPA), KLAS surveyed 55 provider organizations (including hospitals, health systems, academic health centers, and reference labs) to assess the state of digital pathology among pioneers in the US and determine which vendors are gaining traction. - 33 of the interviewed organizations are live with
Read More

KLAS: 7 Key Healthcare Trends in Microsoft Cloud Technologies in 2022

by Syed Hamza Sohail 09/02/2022 Leave a Comment

KLAS: 7 Key Healthcare Trends in Microsoft Cloud Technologies in 2022

What You Should Know: - A new report from KLAS focuses on healthcare-specific deployments of Microsoft Cloud Technologies, especially Microsoft Azure, which is receiving strong market interest. - This study is meant to help organizations considering Microsoft Cloud technologies understand their current use, the overall customer experience, and the impact of the solutions. Key Healthcare Trends in Microsoft Cloud Technologies in 2022 While still early, healthcare is gaining momentum
Read More

Tribun Health, Mindpeak Partner on AI Diagnostic Tool for Breast Cancer for Pathologists

by Syed Hamza Sohail 08/04/2022 Leave a Comment

Tribun Health, Mindpeak Partner on AI Diagnostic Tool for Breast Cancer for Pathologists

What You Should Know: - Tribun Health, the European leader in software development for digital pathology, is pleased to announce a strategic partnership with Mindpeak, a global leader for pathology artificial intelligence (AI) software with world-class industry experts in the development of AI algorithms to provide precision and speed in clinical pathology. - Together, Tribun Health and Mindpeak help pathologists analyze whole-slide-images (WSI) of immunohistochemically (IHC) stained human
Read More

Proscia Raises $37M for AI-Enabled Pathology Platform

by Jasmine Pennic 06/14/2022 Leave a Comment

JPC Taps Proscia to Modernize World's Largest Human Tissue Repository

What You Should Know: - Proscia, a Philadelphia-based provider of digital and computational pathology solutions raises $37M to advance the way we understand and treat diseases like cancer. The round includes participation from Highline Capital Management, Triangle Peak Partners, and Alpha Intelligence Capital as well as existing investors including Scale Venture Partners, Hitachi Ventures, ROBO Global, Emerald Development Managers, and Razor's Edge Ventures. This investment brings Proscia's
Read More

PreciseDx’s AI-Enabled Digital Pathology Proven to Detect Early-Stage Parkinson’s Disease

by Jasmine Pennic 04/20/2022 Leave a Comment

PreciseDx's AI-Enabled Digital Pathology Proven to Detect Early-Stage Parkinson's Disease

What You Should Know: - Mount Sinai spinout, PreciseDx, today announced that its AI-enabled digital pathology is the first proven to detect early-stage Parkinson’s disease, according to a recent research study. - The study, conducted in collaboration with Michael J. Fox Foundation, identified that PreciseDx’s technology can accurately diagnose Parkinson's disease in living patients prior to the severe onset of symptoms. Challenges Diagnosing Parkinson’s
Read More

  • Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 3
  • Go to page 4
  • Go to page 5
  • Go to page 6
  • Go to page 7
  • Go to page 8
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |